Literature DB >> 9111496

Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation.

R B Bressler1, J Lesko, M L Jones, M Wasserman, R R Dickason, M M Huston, S W Cook, D P Huston.   

Abstract

BACKGROUND: The late-phase allergic reaction is an eosinophilic inflammatory response that begins several hours after allergen exposure, may persist for 24 hours, and is an important pathogenic mechanism in allergic disease.
OBJECTIVE: Cultured naive human mast cells were used to investigate whether mast cells are a direct source of the eosinophil-promoting cytokines IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF).
METHODS: Naive human mast cells were derived from bone marrow mononuclear cells cultured in the presence of stem-cell factor. Cytokine message and protein production in response to high-affinity IgE receptor ligation of cultured mast cells were measured by semiquantitative polymerase chain reaction and ELISA, respectively.
RESULTS: IL-5, IL-3, and GM-CSF messenger RNA increased within 2 hours of mast cell activation, with IL-5 and GM-CSF message remaining elevated for 24 hours, whereas IL-3 mRNA rapidly declined. IL-5 and GM-CSF protein were measurable 4 to 6 hours after stimulation and peaked by 24 and 12 hours, respectively. IL-3 protein was not detectable.
CONCLUSION: These findings demonstrate that naive mast cells do not constitutively produce IL-5 or GM-CSF protein but are a major source of these eosinophilotropic cytokines on high-affinity IgE receptor ligation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111496     DOI: 10.1016/s0091-6749(97)70078-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  Interleukin-5, a therapeutic target in allergic inflammation.

Authors:  D P Huston; M M Huston; R R Dickason; M Martinez-Moczygemba
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Importance of mast cells in the pathophysiology of asthma.

Authors:  Seong H Cho; Andrea J Anderson; Chad K Oh
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

3.  The role of mast cells in non-ablative laser resurfacing with 1,320 nm neodymium:yttrium-aluminium-garnet laser.

Authors:  Yingbin Shang; Zhan Wang; Ying Pang; Peng Xi; Qiushi Ren
Journal:  Lasers Med Sci       Date:  2009-06-30       Impact factor: 3.161

Review 4.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  Modulatory effects of connexin-43 expression on gap junction intercellular communications with mast cells and fibroblasts.

Authors:  Ashley L Pistorio; H Paul Ehrlich
Journal:  J Cell Biochem       Date:  2011-05       Impact factor: 4.429

6.  Interleukin-5 reduces the expression of uteroglobin-related protein (UGRP) 1 gene in allergic airway inflammation.

Authors:  Yoshihiko Chiba; Achara Srisodsai; Porntip Supavilai; Shioko Kimura
Journal:  Immunol Lett       Date:  2005-02-15       Impact factor: 3.685

7.  Interleukin-3 production by mast cells from human lung.

Authors:  T Ishizuka; Y Okayama; H Kobayashi; M Mori
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

8.  Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection.

Authors:  Kichul Shin; Gerald F M Watts; Hans C Oettgen; Daniel S Friend; Alan D Pemberton; Michael F Gurish; David M Lee
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

9.  TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice.

Authors:  Laura McKinley; John F Alcorn; Alanna Peterson; Rachel B Dupont; Shernaaz Kapadia; Alison Logar; Adam Henry; Charles G Irvin; Jon D Piganelli; Anuradha Ray; Jay K Kolls
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells.

Authors:  Yui-Hsi Wang; Pornpimon Angkasekwinai; Ning Lu; Kui Shin Voo; Kazuhiko Arima; Shino Hanabuchi; Andreas Hippe; Chris J Corrigan; Chen Dong; Bernhard Homey; Zhengbin Yao; Sun Ying; David P Huston; Yong-Jun Liu
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.